In March 2025, the company declared new strategies for any direct-to-customer featuring of its Wegovy weight loss drug. The company set up a new pharmacy, termed NovoCare, which would demand consumers $499 a month for use of the drug, fewer than 50 percent the price of the drug by other pharmace